金柚宝浓缩饮料

Search documents
中享证券携手富柚生物科技 开启港股上市新征程,共创资本市场宏图
Sou Hu Cai Jing· 2025-09-04 10:40
Group 1 - The core viewpoint of the article highlights the partnership between Zhongxiang Securities and Fuyou Biotechnology, marking the company's journey towards listing on the Hong Kong capital market [1][10] - Fuyou Biotechnology, established in 2014, focuses on the deep processing of the pomelo industry, utilizing a unique development model that integrates companies, research institutions, ecological bases, and farmers [3] - The company has been recognized as a key agricultural leading enterprise in Guangdong Province in 2023, reflecting its significant growth and contribution to the local economy [3] Group 2 - Fuyou Biotechnology operates three fully automated production lines with independent intellectual property rights, ensuring high product quality through advanced processing techniques [5] - The company's pomelo beverage "Jinyou No. 1" has received accolades, including being named a "Guangdong Province Famous Brand Product" and designated as the reception beverage for the Sixth World Business Conference [5] - The company has achieved various certifications, including ISO9000 quality management system certification and recognition as a national high-tech enterprise [5] Group 3 - Zhongxiang Securities will assist Fuyou Biotechnology in restructuring its equity and assets to comply with legal and regulatory requirements for the Hong Kong listing [7] - The firm will help the company enhance its financial management and coordinate audits to meet international accounting standards [8] - Zhongxiang Securities will prepare the necessary listing documents and facilitate communication with regulatory bodies, ensuring a smooth transition to the capital market [8] Group 4 - The partnership is seen as a significant milestone for Fuyou Biotechnology, aiming to enhance brand influence, broaden financing channels, and accelerate the implementation of its development plans [10] - Zhongxiang Securities aims to provide comprehensive capital market solutions, ensuring an efficient and stable listing process for Fuyou Biotechnology [10]